BeiGene Ownership | Who Owns BeiGene?
BeiGene Ownership Summary
BeiGene is owned by 41.22% institutional investors, 19.43% insiders, and 39.35% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 9.00% of BGNE shares. American Funds New Perspective A is the top mutual fund, with 2.63% of its assets in BeiGene shares.
BGNE Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | BeiGene | 41.22% | 19.43% | 39.35% |
Sector | Healthcare Stocks | 57.43% | 9.41% | 33.16% |
Industry | Biotech Stocks | 69.02% | 8.92% | 22.06% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Baker bros. advisors lp | 9.53M | 9.00% | $1.76B |
Capital investors | 6.11M | 5.77% | $1.13B |
Primecap management co/ca/ | 5.10M | 4.81% | $941.82M |
Hhlr advisors | 3.80M | 3.59% | $702.71M |
Baillie gifford | 3.67M | 3.47% | $678.11M |
Price t rowe associates inc /md/ | 2.94M | 2.77% | $542.52M |
Fmr | 1.85M | 1.75% | $341.36M |
Temasek (private) | 1.53M | 1.44% | $281.74M |
Blackrock | 959.19K | 0.71% | $136.85M |
Blackrock funding, inc. /de | 733.98K | 0.69% | $135.57M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Hhlr advisors | 3.80M | 24.34% | $702.71M |
Baker bros. advisors lp | 9.53M | 18.81% | $1.76B |
Siren | 653.72K | 5.33% | $120.75M |
Paradigm biocapital advisors lp | 616.02K | 3.96% | $113.79M |
Jgp global gestao de recursos ltda. | 9.37K | 3.94% | $1.73B |
Boxer capital | 500.00K | 3.76% | $71.33M |
Nan fung group | 20.00K | 3.16% | $3.69M |
Long corridor asset management | 18.40K | 2.55% | $3.40M |
Xy capital | 24.60K | 2.19% | $4.54M |
Exome asset management | 10.00K | 1.39% | $1.85M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Paradigm biocapital advisors lp | 616.02K | 3.96% | 415.69K |
Nuveen asset management | 405.21K | 0.02% | 242.56K |
Price t rowe associates inc /md/ | 2.94M | 0.06% | 237.08K |
Fmr | 1.85M | 0.02% | 188.05K |
Primecap management co/ca/ | 5.10M | 0.73% | 124.61K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Hhlr advisors | 3.80M | 24.34% | -1.37M |
Baker bros. advisors lp | 9.53M | 18.81% | -1.04M |
Temasek (private) | 1.53M | 1.11% | -863.25K |
Point72 asset management | 25.17K | 0.01% | -642.00K |
Vestal point capital, lp | - | - | -350.00K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 100.01K | 0.00% | 100.01K | $18.47M |
Healthcare of ontario pension plan trust fund | 87.20K | 0.03% | 87.20K | $16.11M |
Canada pension plan investment board | 50.00K | 0.01% | 50.00K | $9.24M |
Balyasny asset management | 44.29K | 0.01% | 44.29K | $8.18M |
Qube research | 15.19K | 0.00% | 15.19K | $2.81M |
Sold Out
Holder | Change |
---|---|
Financial gravity asset management | -1.00 |
Central trust | -1.00 |
Advisornet financial | -2.00 |
Concourse financial group securities | -3.00 |
Pacific capital wealth advisors | -3.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 230 | -3.36% | 43,657,183 | -6.07% | 41 | 2.14% | 111 | 1.83% | 75 | -12.79% |
Sep 30, 2024 | 234 | 14.15% | 46,472,316 | -0.63% | 43 | 3.69% | 107 | 17.58% | 84 | 27.27% |
Jun 30, 2024 | 203 | -1.93% | 46,765,610 | 0.79% | 34 | 1.75% | 90 | -29.69% | 65 | 41.30% |
Mar 31, 2024 | 207 | -0.96% | 46,399,493 | 3.32% | 44 | 4.08% | 128 | 37.63% | 46 | -37.84% |
Dec 31, 2023 | 209 | 1.95% | 44,906,761 | -4.78% | 33 | 1.62% | 93 | 5.68% | 74 | 7.25% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
American Funds New Perspective A | 2.80M | 2.63% | - |
Capital Group New Perspective Comp | 2.80M | 2.63% | - |
Vanguard PRIMECAP Inv | 2.31M | 2.16% | 105.00K |
American Funds New World A | 1.16M | 1.08% | - |
Capital Group New Geography Equity Comp | 1.16M | 1.08% | - |
Vanguard Capital Opportunity Inv | 1.12M | 1.05% | 37.50K |
T. Rowe Price Health Sciences | 725.72K | 0.68% | -17.51K |
PRIMECAP Odyssey Aggressive Growth | 698.89K | 0.66% | -6.07K |
T. Rowe Price International Gr Eq Tr-D | 673.60K | 0.63% | 86.03K |
PRIMECAP Odyssey Growth | 671.43K | 0.63% | -12.30K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 10, 2025 | OYLER JOHN | Chief Executive Officer | Sell | $529.53K |
Mar 10, 2025 | OYLER JOHN | Chief Executive Officer | Sell | $1.71M |
Mar 10, 2025 | OYLER JOHN | Chief Executive Officer | Sell | $453.61K |
Mar 10, 2025 | OYLER JOHN | Chief Executive Officer | Sell | $1.63M |
Mar 10, 2025 | OYLER JOHN | Chief Executive Officer | Sell | $2.26M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 79 |
2024 Q4 | - | 47 |
2024 Q3 | - | 12 |
2024 Q2 | - | 38 |
2024 Q1 | - | 15 |
BGNE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools